Porphyromonas gingivalis fimbriae (P. gingivalis fimbriae)

Porphyromonas gingivalis fimbriae are extracellular proteinaceous appendages that serve as critical virulence factors for this keystone periodontal pathogen (NCBI, PMC4212503). These structures are categorized into major fimbriae, composed of the FimA protein, and minor fimbriae, composed of Mfa1, both of which mediate bacterial attachment to oral epithelial cells, fibroblasts, and other bacteria within dental biofilms (PubMed, 26431610). By interacting with host cell receptors such as Toll-like receptor 2 (TLR2) and alpha-v beta-3 integrins, fimbriae facilitate both colonization and the invasion of host tissues, leading to the chronic inflammatory state characteristic of periodontitis (UniProt, P14619). Beyond oral health, P. gingivalis fimbriae have been implicated in systemic inflammatory conditions, including cardiovascular disease and Alzheimer's disease, as they assist the bacteria in entering the bloodstream and crossing the blood-brain barrier (PubMed, 30679222). Therapeutic strategies targeting these fimbriae include the development of subunit vaccines and small-molecule adhesion inhibitors designed to block the initial stages of infection and mitigate the pathogen's systemic impact (PubMed, 24694403). At a glance, these structures represent a primary target for disrupting the ecological niche of P. gingivalis and preventing the progression of chronic inflammatory diseases.

Other names

Porphyromonas gingivalis piliFimAMfa1FimbrilinMajor fimbriaeMinor fimbriae

Neutralization of bacterial adhesion, competitive inhibition of fimbrial binding to host integrins/TLRs, and induction of protective mucosal and systemic immunity via vaccination.